◆ Blood cell analysis

◆ Routine blood chemistry panel

◆ Four tests of coagulation

◆ Urine dry chemistry and urine sediment microscopy

◆ Immunophenotyping of blood lymphocytes, e.g. CD3+, CD4+, CD8+, CD16+, CD20+, CD161a+, CD45RA+.

◆ Immunophenotyping of organ lymphocytes, e.g. T cells (CD3-FITC/CD4-PE/CD8a-PerCP), NK-cells (CD3-CD161+) and B cells (CD3-CD45+) of thymus and spleen.

                                               NK-cells (CD3-CD161+) and Bcells (CD3-CD45+)

◆ Detection of various cytokines, e.g. IL-2, IL-4, IL-5, IL-6, IL-10, TNF-α, IFN-γ, IL-12P70, MCP-1.

◆  Receptor occupancy (RO) detection, e.g. PD-1 (CD279).

◆  T-reg cell subtype analysis, e.g. CD4+CD25+FoxP3+

◆ Immunoglobulin and complement detection, e.g. IgG, IgM, IgA, C3, C4.

◆ Lipoprotein and glycated hemoglobin detection, e.g. HDL, LDL, HBA1c.

◆ Quantitative analysis of urine, e.g. UUA, UCRE, UURE, UGLU, UTP, UAMY.

◆ Platelet aggregation detection, e.g. AA, ADP, COL, EPI, RIS.

◆ Detection of exogenous coagulation factor activity, e.g. II, V, VII, X. 

◆ Detection of endogenous coagulation factor activity, e.g. VIII, IX, XI, XII.

◆ Fibrin degradation products, e.g. FDP, D-Dimer.

◆ Other coagulation factors and protein detection, e.g. FXIII, FVIII, VWF, Hep, PS, PC, LA, AT.